DV Trading’s Ascendis Pharma A/S ASND Stock Holding History

DV Trading’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$213	–	521
2025 Q4	$213	Buy	+1	New	+$207	﹤0.01%	1015

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DV Trading's ASND Position: Q1 2026 in Review

DV Trading sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 1 share — an estimated $213 sold.

DV Trading first reported a position in ASND in Q4 2025 and held it in 1 quarter. The position peaked at $213 in Q4 2025. 274 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

DV Trading reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
DV Trading sold 1 Ascendis Pharma A/S share in Q1 2026, an estimated $213.
DV Trading first reported a position in Ascendis Pharma A/S in Q4 2025 and held it in 1 quarter.
DV Trading's Ascendis Pharma A/S position peaked at $213 in Q4 2025.
274 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on DV Trading's 13F filing for Q1 2026, filed 15 May 2026.